On August 27th, Altria Group and its operating company NJOY responded to the preliminary ruling by the Administrative Law Judge (ALJ) of the United States International Trade Commission (ITC) regarding a patent infringement lawsuit filed by JUUL Labs.
According to reports, last week an administrative judge issued a notification supporting JUUL's accusations in a lawsuit and recommended issuing an exclusion order to ban NJOY ACE products from being imported into the United States.
Occhia and NJOY both expressed respect for the preliminary ruling, but disagreed with it. NJOY looks forward to presenting its position to the full ITC committee, which is expected to make a final decision on December 23 of this year.
In August of this year, NJOY filed a similar and independent patent infringement lawsuit against ITC, seeking to ban the import and sale of JUUL products in the United States. The hearing for this case is scheduled for June 2024, with a preliminary ruling expected to be issued by the end of September this year. It is worth noting that even if a favorable ruling is obtained in this case, it will not prevent the injunction against ACE products from taking effect.
Currently, all parties have attempted mediation through a mediator, and Ochiai has promised to work towards resolving the issue.
Furthermore, NJOY recently submitted a substantial equivalence (SE) exemption request to the US Food and Drug Administration (FDA) to allow it to sell modified ACE products, which the company believes can bypass three of the four JUUL patents involved in this case.
It is worth noting that ACE is the first pod-based electronic vaping product and the only mint-flavored pod electronic vaping product approved by the FDA that is suitable for protecting public health.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
